(DOCS) Doximity - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US26622P1075

DOCS: Cloud, Platform, Tools, Software, Network, Healthcare, Technology

Doximity, Inc. (NYSE:DOCS) is a cloud-based digital platform designed specifically for medical professionals in the United States. It serves as a professional network akin to LinkedIn but tailored for doctors, offering a suite of tools that enhance collaboration, knowledge sharing, and practice management. The platforms features include secure messaging, a medical newsfeed, career management tools, and telemedicine capabilities, making it an essential resource for physicians, nurse practitioners, and healthcare organizations.

The companys strategic advantage lies in its network effects. As more medical professionals join, the platform becomes increasingly valuable, creating a virtuous cycle that solidifies its position in the market. This specialization allows Doximity to address unique challenges in healthcare communication and collaboration more effectively than general-purpose platforms.

Doximitys financial profile reflects its growth trajectory. With a market capitalization exceeding $14 billion, it is a significant player in the health technology sector. The trailing P/E ratio of approximately 77 and a forward P/E of 52 suggest that investors anticipate substantial future growth. The price-to-sales ratio of nearly 28 indicates a premium valuation, typical of high-growth tech companies.

For investors, Doximity represents a compelling opportunity in the healthcare technology space, particularly as digital transformation continues to reshape the industry. Its focus on serving medical professionals positions it well to capitalize on the growing need for efficient, secure, and specialized digital solutions in healthcare.

Additional Sources for DOCS Stock

DOCS Stock Overview

Market Cap in USD 12,377m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2021-06-24

DOCS Stock Ratings

Growth 5y 17.0%
Fundamental 55.7%
Dividend 0.0%
Rel. Strength Industry 126
Analysts 3.53/5
Fair Price Momentum 64.14 USD
Fair Price DCF 14.35 USD

DOCS Dividends

No Dividends Paid

DOCS Growth Ratios

Growth Correlation 3m 77.2%
Growth Correlation 12m 94.4%
Growth Correlation 5y -36%
CAGR 5y 4.92%
CAGR/Max DD 5y 0.06
Sharpe Ratio 12m 0.52
Alpha 111.14
Beta 1.88
Volatility 63.03%
Current Volume 1739.1k
Average Volume 20d 2387.9k
What is the price of DOCS stocks?
As of March 15, 2025, the stock is trading at USD 63.38 with a total of 1,739,073 shares traded.
Over the past week, the price has changed by -0.94%, over one month by -17.76%, over three months by +18.96% and over the past year by +127.58%.
Is Doximity a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Doximity (NYSE:DOCS) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 55.68 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DOCS as of March 2025 is 64.14. This means that DOCS is currently overvalued and has a potential downside of 1.2%.
Is DOCS a buy, sell or hold?
Doximity has received a consensus analysts rating of 3.53. Therefor, it is recommend to hold DOCS.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 13
  • Sell: 0
  • Strong Sell: 0
What are the forecast for DOCS stock price target?
According to ValueRays Forecast Model, DOCS Doximity will be worth about 73.8 in March 2026. The stock is currently trading at 63.38. This means that the stock has a potential upside of +16.5%.
Issuer Forecast Upside
Wallstreet Target Price 74.9 18.2%
Analysts Target Price 55.1 -13%
ValueRay Target Price 73.8 16.5%